CymitQuimica logo
Angiogénesis

Angiogénesis

Los inhibidores de la angiogénesis son compuestos que interfieren con la formación de nuevos vasos sanguíneos, un proceso crucial en el crecimiento y la metástasis del cáncer. Al inhibir la angiogénesis, estos compuestos pueden restringir el suministro de sangre a los tumores, ralentizando o deteniendo su crecimiento. Los inhibidores de la angiogénesis son esenciales en la investigación del cáncer y en el desarrollo terapéutico, proporcionando información sobre los mecanismos de progresión tumoral y ofreciendo posibles tratamientos para el cáncer y otras enfermedades relacionadas con la angiogénesis. En CymitQuimica, ofrecemos una amplia gama de inhibidores de la angiogénesis de alta calidad para apoyar su investigación en oncología y biología vascular.

Subcategorías de "Angiogénesis"

Mostrar 6 subcategorías más

Se han encontrado 2254 productos de "Angiogénesis"

Ordenar por

Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
productos por página.
  • TYK2 activator-1


    TYK2activator-1 (16b) is a TYK2 activator with an EC50 value of 1.78 μM. It inhibits JAK2 and JAK3 with IC50 values of 6.8 μM and 6.3 μM, respectively.
    Fórmula:C23H21FN4O2
    Forma y color:Solid
    Peso molecular:404.16485

    Ref: TM-T207637

    10mg
    A consultar
    50mg
    A consultar
  • GBD-9

    CAS:
    GBD-9, a dual-mechanism degrader, effectively promotes the degradation of BTK and GSPT1 through recruitment of E3 ligase cereblon (CRBN).
    Fórmula:C44H47N9O6
    Pureza:98%
    Forma y color:Solid
    Peso molecular:797.9

    Ref: TM-T79139

    5mg
    A consultar
    50mg
    A consultar
  • Amuvatinib hydrochloride

    CAS:
    Amuvatinib HCl (MP470 HCl) is a multi-targeted oral tyrosine kinase inhibitor and hinders RAD51-mediated DNA repair, exhibiting anticancer properties.
    Fórmula:C23H22ClN5O3S
    Pureza:98%
    Forma y color:Solid
    Peso molecular:483.97

    Ref: TM-T14282

    25mg
    A consultar
    50mg
    A consultar
    100mg
    A consultar
  • SI-2

    CAS:
    SI-2, a SRC-3 inhibitor, triggers breast cancer cell death (IC50: 3-20 nM), sparing normal cells.
    Fórmula:C15H15N5
    Pureza:98.4%
    Forma y color:Solid
    Peso molecular:265.31

    Ref: TM-T28773

    1mg
    378,00€
    5mg
    922,00€
    10mg
    1.225,00€
    25mg
    1.853,00€
    50mg
    2.490,00€
    100mg
    3.353,00€
    1mL*10mM (DMSO)
    845,00€
  • 7-Hydroxyneolamellarin A

    CAS:
    7-Hydroxyneolamellarin A, from Dendrilla nigra, inhibits HIF-1α and VEGF in cancer research.
    Fórmula:C24H19NO5
    Forma y color:Solid
    Peso molecular:401.41

    Ref: TM-T75487

    5mg
    A consultar
    50mg
    A consultar
  • SNIPER(ABL)-047


    SNIPER(ABL)-047, a compound that links HG-7-85-01 (an ABL inhibitor) to MV-1 (an IAP ligand) via a linker, effectively decreases the BCR-ABL protein levels,
    Fórmula:C67H82F3N11O9S
    Pureza:98%
    Forma y color:Solid
    Peso molecular:1274.5

    Ref: TM-T18692

    100mg
    A consultar
    500mg
    A consultar
  • SJ10542

    CAS:
    SJ10542: potent JAK2/3-targeting PG-PROTAC; DC50s: JAK2 - 14 nM, JAK3 - 11 nM, JAK2-fusion ALL - 24 nM; CRBN recruiter.
    Fórmula:C41H46N12O5S
    Forma y color:Solid
    Peso molecular:818.95

    Ref: TM-T74429

    2mg
    1.288,00€
  • HER2/neu (654-662) GP2

    CAS:
    Phage display selected Affibody ligands for HER2/neu from a protein library based on a 58-residue Staphylococcal protein A Z domain.
    Fórmula:C42H77N9O11
    Pureza:98%
    Forma y color:Solid
    Peso molecular:884.11

    Ref: TM-TP1583

    100mg
    A consultar
    500mg
    A consultar
  • JAK/HDAC-IN-2


    JAK/HDAC-IN-2, a potent 2-amino-4-phenylaminopyrimidine dual-target inhibitor, effectively suppresses JAK1/2 and HDAC3/6 at nanomolar concentrations.
    Fórmula:C28H38N6O5S
    Pureza:98%
    Forma y color:Solid
    Peso molecular:570.7

    Ref: TM-T78708

    5mg
    A consultar
    50mg
    A consultar
  • BW710


    BW710 is an orally active inhibitor specifically targeting fibroblast growth factor receptor 2 (FGFR2). It effectively inhibits the proliferation of BaF3-FGFR2 cells with an IC50 value of 2.8 nM. BW710 completely suppresses FGFR2 enzymatic activity and demonstrates selectivity among 75 tyrosine kinases, including FGFR1, FGFR3, and FGFR4, at a 1 μM concentration. Additionally, BW710 impedes FGFR2 signaling and selectively inhibits the proliferation of cancer cells driven by FGFR2. It exhibits promising pharmacokinetic properties, with an oral bioavailability of 29% in mice.

    Fórmula:C28H29FN6O2S
    Forma y color:Solid
    Peso molecular:532.63

    Ref: TM-T205382

    10mg
    A consultar
    50mg
    A consultar
  • Axltide

    CAS:
    Axltide mimics mouse Insulin receptor substrate 1, amino acids 979-989 with sequence KKSRGDYMTMQIG.
    Fórmula:C63H107N19O20S2
    Pureza:98%
    Forma y color:Solid
    Peso molecular:1514.77

    Ref: TM-TP1713

    100mg
    A consultar
    500mg
    A consultar
  • Tephrosin

    CAS:
    Tephrosin induces degradation of of EGFR and ErbB2 by inducing internalization of the receptors, has potent antitumor activities.
    Fórmula:C23H22O7
    Pureza:98%
    Forma y color:Solid
    Peso molecular:410.42

    Ref: TM-T13126

    5mg
    882,00€
  • MET/PDGFRA-IN-1


    MET/PDGFRA-IN-1 (compound 8c) serves as an inhibitor of MET and PDGFRA proteins, displaying an IC50 of 36 μM against MET.
    Fórmula:C26H23N7O
    Pureza:98%
    Forma y color:Solid
    Peso molecular:449.51

    Ref: TM-T78843

    5mg
    A consultar
    50mg
    A consultar
  • ALK-IN-13

    CAS:

    ALK-IN-13 is an ALK inhibitor.

    Fórmula:C29H39ClN7O2P
    Forma y color:Solid
    Peso molecular:584.1

    Ref: TM-T38583

    5mg
    922,00€
  • hCA/VEGFR-2-IN-2


    Compound 8g (hCA/VEGFR-2-IN-2) is an indolinonylbenzenesulfonamide identified as a potential dual inhibitor targeting cancer-associated isozymes hCA IX/XII and
    Fórmula:C23H26N6O5S
    Pureza:98%
    Forma y color:Solid
    Peso molecular:498.55

    Ref: TM-T79587

    5mg
    A consultar
    50mg
    A consultar
  • Multi-kinase-IN-6


    Multi-kinase-IN-6 (compound 10e) is a multikinase inhibitor that effectively impedes the activity of TrkA, ALK2, c-KIT, EGFR, PIM1, CK2α, CHK1, and CDK2.
    Pureza:98%
    Forma y color:Odour Solid

    Ref: TM-T81740

    5mg
    A consultar
    50mg
    A consultar
  • BCR-ABL-IN-3

    CAS:
    BCR-ABL-IN-3 irreversibly inhibits Bcr-Abl with <100 nM IC50, showing significant anti-cancer effects.
    Fórmula:C20H17ClF2N4O3S
    Forma y color:Solid
    Peso molecular:466.89

    Ref: TM-T39732

    5mg
    873,00€
  • EGFR/BRAFV600E-IN-4


    EGFR/BRAFV600E-IN-4 (Compound 10f) is a dual inhibitor of EGFR and BRAFV600E, with IC50 values of 61 nM and 43 nM, respectively. It halts the cell cycle, induces apoptosis in both early and late stages, and inhibits cancer cell growth in vitro, showing broad-spectrum anticancer activity.
    Fórmula:C22H16N4OS
    Forma y color:Solid
    Peso molecular:384.45

    Ref: TM-T205664

    10mg
    A consultar
    50mg
    A consultar
  • DSPE-PEG1000-A7R


    DSPE-PEG1000-A7R is a PEG compound consisting of DSPE and the tumor vasculature-targeting peptide (A7R). A7R exhibits high affinity and specificity for VEGFR-2, which is overexpressed in various tumors.
    Forma y color:Odour Solid

    Ref: TM-TCL-01141

    10mg
    A consultar
    50mg
    A consultar
  • MET/PDGFRA-IN-2


    MET/PDGFRA-IN-2 (compound 8h) serves as an inhibitor of MET and PDGFRA proteins, promoting apoptosis in cells and impeding the proliferation of MET-positive
    Fórmula:C29H29N7O
    Pureza:98%
    Forma y color:Solid
    Peso molecular:491.59

    Ref: TM-T78844

    5mg
    A consultar
    50mg
    A consultar